Nifty Quality 30 News and Updates

Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 4
Author: KRChoksey

Keep track of all breaking news on Nifty Quality 30 from all sources in a single place.

Load latest

Infosys Ltd.

13 May 2025

1571.80

0.11%

Infosys signals lower Q4 bonus payouts for employees amid profit decline

Business Standard

Infosys has informed some employees of lower Q4 FY25 bonus payouts citing profit decline while calling the move temporary and promising better recommendations once growth returns

Number of FII/FPI investors increased from 1758 to 1775 in Mar 2025 qtr.

Hero MotoCorp Ltd.

13 May 2025

4362.20

0.55%

to see Rapid results content

Infosys Ltd.

13 May 2025

1571.80

0.11%

Infosys, Coforge, Sagility Favoured By Jefferies Amid Muted IT Sector Outlook

NDTV Profit

The brokerage noted that overall revenue growth for IT firms worsened in the fourth quarter of financial year 2025, with large-cap companies reporting sequential revenue declines.

Infosys Ltd. is trading below its 100 day SMA of 1686.3

Asian Paints Ltd.

13 May 2025

2303.20

-1.05%

Birla's big paints bet hits Asian Paints' market share in just one year

Business Standard

Birla Opus' market share reached 6.8 per cent in the latest quarter

Asian Paints Ltd. is trading below all available SMAs

Asian Paints stares at weak FY26 on margin strain, market share loss

Business Standard | 12 May 2025

Dr. Reddy's Laboratories Ltd.

13 May 2025

1242.60

-0.05%

Momentum in revenue growth to continue with new launches

Accumulate: Dr. Reddy's Laboratories Ltd.

Target

KRChoksey

During Q4FY25, Dr. Reddy’s revenue stood at INR 85,284 Mn, up 19.9% YoY (+1.8% QoQ), above our estimates by 3.6%, driven by growth across key markets.
EBITDA stood at INR 20,747 Mn, up by 14.4% YoY (-8.7% QoQ), below our estimates by 7.0%, led by contraction in gross margins.

Dr. Reddy's Laboratories Ltd. is trading below its 200 day SMA of 1258.2

Britannia Industries Ltd.

13 May 2025

5473.00

-0.43%

Volume-led growth supported by premiumization; margin pressure continues

Accumulate: Britannia Industries Ltd.

Target

KRChoksey

During Q4FY25, Britannia’s Q4FY25 earnings outperformed our estimates, reflecting strong volume growth. Revenue stood at INR 44,322 Mn, up 8.9% YoY (-3.5% QoQ), in-line with our estimates (+1.1%), driven by high single-digit volume growth.